|
European Questionnaire on Drug Use among Prisoners (EQDP) and Methodological guidelines |
prison |
|
Health responses to new psychoactive substances |
best practice | emerging topics | health effects | injection | new psychoactive substances (NPS) | prevention | prison | problem drug use | recreational drugs | synthetic drugs | synthetic stimulants | treatment | young people |
|
Alternatives to punishment for drug-using offenders |
best practice | crime | criminal justice | drug-law offences | other topics | policy | prison | social reintegration |
|
European Drug Report 2015: Trends and Developments |
alcohol | amphetamines | cannabis | chemistry | co-morbidity | cocaine | consumption rooms | crime | death | demand | drug-law offences | environmental indicators | epidemiology | evaluation | gender | hallucinogens | harm reduction | health effects | heroin | HIV | infectious diseases | injecting | key indicators | law | markets | methodology | new psychoactive substances (NPS) | older people | opioids | overdose | policy | polydrug use | prevalence | prevention | price | prison | problem drug use | public expenditure | purity | recreational drugs | Reitox | research | seizures | social exclusion | social reintegration | spice | statistics | strategies | substitution treatment | supply | synthetic stimulants | trafficking | treatment | trends | young people |
|
2009 Annual report on the state of the drugs problem in Europe |
amphetamines | cannabis | co-morbidity | cocaine | demand | drug-law offences | emcdda | epidemiology | evaluation | hallucinogens | harm reduction | health effects | heroin | HIV | infectious diseases | injecting | law | markets | new psychoactive substances (NPS) | opioids | overdose | policy | polydrug use | prevalence | prevention | price | prison | problem drug use | public expenditure | purity | recreational drugs | research | seizures | social exclusion | social reintegration | spice | strategies | substitution treatment | supply | synthetic stimulants | trafficking | treatment | trends |
|
European Drug Report 2013: Trends and developments |
amphetamines | cannabis | cocaine | consumption rooms | crime | death | health effects | heroin | HIV | infectious diseases | injecting | key indicators | law | markets | new psychoactive substances (NPS) | opioids | overdose | policy | prevalence | prevention | prison | seizures | social reintegration | statistics | substitution treatment | supply | treatment | trends |
|
European Drug Report 2014: Trends and developments |
amphetamines | cannabis | cocaine | crime | death | demand | drug-law offences | harm reduction | health effects | heroin | infectious diseases | injecting | key indicators | markets | new psychoactive substances (NPS) | opioids | overdose | policy | prevalence | prevention | price | prison | problem drug use | recreational drugs | seizures | statistics | strategies | substitution treatment | supply | synthetic stimulants | trafficking | treatment | trends | young people |
|
2010 Annual report on the state of the drugs problem in Europe |
amphetamines | cannabis | co-morbidity | cocaine | crime | death | demand | drug-law offences | emcdda | epidemiology | gender | hallucinogens | health effects | heroin | HIV | infectious diseases | injecting | key indicators | law | markets | new psychoactive substances (NPS) | opioids | overdose | policy | polydrug use | prevalence | prevention | price | prison | problem drug use | public expenditure | purity | recreational drugs | research | seizures | social exclusion | social reintegration | spice | strategies | substitution treatment | supply | synthetic stimulants | trafficking | treatment | trends |
|
Estimating public expenditure on drug-law offenders in prison in Europe |
prison | public expenditure |
|
Drug use in prison: assessment report |
methodology | prison |